Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-β1 autocrine stimulation

Journal of Periodontal Research

Volumn 34, Issue 8, 1999, Pages 457-463

  Coletta, Ricardo D ^a,b   Almeida, Oslei P ^a   Reynolds, Mark A ^b   Sauk, John J ^b,c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Dental School   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Hereditary gingival fibromatosis; Matrix metalloproteinases; Tissue inhibitor of matrix metalloproteinases; Transforming growth factor 1

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; PRIMER DNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; GINGIVA FIBROMATOSIS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; FIBROBLASTS; FIBROMATOSIS, GINGIVAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GINGIVA; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033219402     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1999.tb02281.x     Document Type: Article

References (45)

1. Bozzo L, Almeida OP, Scully C, Aldred MJ. Hereditary gingival fibromatosis: report of an extensive four-generation pedigree. Oral Surg Oral Med Oral Pathol 1994;78:452-454.
2. Gorlin RJ, Cohen MM, Levin LS. Syndromes of the head and neck, 3rd edn. New York. Oxford University Press, 1990; 847-858.
3. Shirasuna K, Okura M, Watatani K, Hayashido Y, Saka M. Matsuya T. Abnormal cellular property of fibroblasts from congenital gingival fibromatosis. J Oral Pathol 1989;7: 381-385.
4. Tipton DA, Howell KJ, Dabbous MK. Increased proliferation, collagen, and fibronectin production by hereditary gingival fibromatosis fibroblasts. J Periodontol 1997;68: 524-530.
5. Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 1997;29:43-54.
6. Fukuda Y, Ishizaki M, Kudoh SD, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinases in interstitial lung diseases. Lab Invest 1998;78:687-698.
7. Iredale JP, Pickering BJ, Northrop MM, Hovell PC, Arthur MJP. Mechanisms of spontaneous resolution of rat liver fibrosis. J Clin Invest 1998;102:538-549.
8. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998;2:466-471.
9. Bikerdal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64: 474-484.
10. Knauper V, Osthues A, DeClerck YA, Langley KE, Blasser J, Tschesche H. Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem J 1993;291: 847-854.
11. Autio-Harmainen H, Karttunen T, Hurskainen T, Hoyhtya M, Kauppila A, Tryggvason K. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 1993;69:321-321.
12. Okada Y, Naka K, Kawamura K et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995;72:311-322.
13. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995;55:1856-1862.
14. Woodhouse EC, Chuaqui RF. Liotta LA. General mechanisms of metastasis. Cancer 1997;80(suppl. 8):1529-1537.
15. Peters CA, Freeman MR, Fernandez CA, Shepard J, Wiederschain DG, Moses MA. Dysregulated proteolylic balance as the basis of excess extracellular matrix in fibrotic disease. Am J Physiol 1997;272:R1960-R1965.
16. Overall C, Wrana JL, Sodek J. Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. J Biol Chem 1991;266:14064-14071.
17. Milani S, Herbst H, Schuppan D et al. Differential expression of matrix-metalloproteinases-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144: 528-537.
18. Herbst H, Wege T, Milani S et al. Tissue inhibitor of metalloproteinases-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 1997;150:1647-1659.
19. Edwards DR, Rocheleau H, Sharma RR et al. Involvement of API and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochem Biophys Acta 1992;1171:41-55.
20. Overall CM, Wrana JL, Sudek J. Independent regulation of collagenase, 72 kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989;264:1860-1869.
21. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kuppfer cell-derived transforming growth factor beta; implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990;11:599-605.
22. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE. Transforming growth factor-beta enhances integrin expression and type-IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 1993;90:4577-4581.
23. James JA, Irwin CR, Linden GJ. Gingival fibroblasts response to cyclosporin and transforming growth factor beta 1. J Periodont Res 1998;33:40-48.
24. Johnson BD, El-Guindy M, Ammons W, Narayanan S, Page R. A defect in fibroblasts from an unidentified syndrome with gingival hyperplasia as the predominant feature. J Periodont Res 1985;21:403-413.
25. Oikarinen K, Salo T, Kaar ML, Lahtela P, Altonen M. Hereditary gingival fibromatosis associated with growth hormone deficiency. Br J Oral Maxillofac Surg 1990;28: 335-339.
26. Coletta RD, Almeida OP, Graner E, Page RC, Bozzo L. Differential proliferation of fibroblasts cultured from hereditary gingival fibromatosis and normal gingiva. J Periodont Res 1998;33:469-475.
27. Chomezynshi P, Sacchi N. Single-step method of RNA isolation by acid guanidinium-phenol chloroform extraction. Anal Biochem 1987;162:156-159.
28. Onisto M, Garbisa S, Caenazzo C et al. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn Mol Pathol 1993;2:74-80.
29. Kubota T, Kubota E, Matsumoto A et al. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder. Eur J Oral Sci 1998;106:992-998.
30. + peripheral blood progenitors and increases the number of transduced progenitors. Exp Hematol 1998;26:374-381.
31. Defacque H, Piquemal D, Basset A, Marti J, Commes T. Transforming growth factor-β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. J Cell Physiol 1999;178:109-119.
32. Tipton DA, Dabbous MK. Autocrine transforming growth factor beta stimulation of extracellular matrix production by fibroblasts from fibrotic human gingiva. J Periodontol 1998;69:609-619.
33. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990;265:13933-13938.
34. Milani S, Herbst H, Scuppan D, Stein H, Surrenti C. Transforming growth factor-β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139: 1221-1229.
35. Alevizopoulos A, Dusserre Y, Ruegg U, Mermod N. Regulation of the transforming growth factor beta-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV. J Biol Chem 1997; 272:23597-23605.
36. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
37. Klim Y, Ratziu V, Choi SG et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf 9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 1998;273:33750-33758.
38. Coletta RD, Almeida OP, Ferreira L, Reynolds MA, Sauk JJ. Increase in expression of Hsp47 and collagen in hereditary gingival fibromatosis is modulated by stress and terminal procollagen N-propeptides. Conn Tis Res 1999; in press.
39. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995;270:5872-5876.
40. Thomason JM, Sloan P, Seymour RA. Immunolocalization of collagenase (MMP-1) and stromelysin (MMP-3) in the gingival tissues of organ transplant patients medicated with cyclosporin. J Clin Periodontol 1998;25:554-560.
41. Shin GT, Khanna A, Ding R, Sharma VK, Lagman M, Li B, Suthanthiran M. In vivo expression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine. Transplantation 1998;65:313-318.
42. Duymelinck C, Deng JT, Dauwe SE, De Broe ME, Verpooten GA. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int 1998;54:804-818.
43. Bou-Gharios G, Osman J, Black C, Oslen I. Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 1994;231:69-78.
44. Lafuma C, El Nabout RA, Crechet F, Hovnanian A, Martin M. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis. J Invest Dermatol 1994;102:945-950.
45. Hart TC, Pallos D, Bowden DW, Bolyard J, Pettenati MJ, Cortelli JR. Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21. Am J Hum Genet 1998;62: 876-883.